GABA level and GAD activity in human and mouse normal and neoplastic mammary gland

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 2, 1999, Pages 247-253

  Mazurkiewicz, M ^a   Opolski, A ^b   Wietrzyk, J ^b   Radzikowski, C ^b   Kleinrok, Z ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

16 C adenocarcinoma; Breast tumors; GABA; GABA ergic system; GAD; Mammary cancer; Mammary gland

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; GLUTAMATE DECARBOXYLASE;

4 AMINOBUTYRIC ACID RELEASE; ADULT; AGED; AMINO ACID ANALYSIS; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER IMMUNOLOGY; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032794813     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Erdo S.L.: Non-neuronal GABA system; an overviev. In: GABA-ergic mechanisms in the mammalian periphery. Edited by SL Erdo and NG Bowery. Raven Press, New York, 1986, 97-110.
2. Martin D.L., Rimval K.: Regulation of GABA synthesis in the brain. J. Neurochem. 60: 395-401. 1993.
3. Paulsen R.E., Odden E., Fonnum F.: Importance of glutamine for GABA synthesis in rat neostriatum in vivo. J. Neurochem. 51: 1294-1299. 1988.
4. Curtis D.R., Johnston G.A.: Aminoacid transmitters in the mammalian central nervous system. Ergeb. Physiol. 64: 98-103. 1974.
5. Myers M.E.: Head and neck oncology. Diagnosis, treatment and rehabilitation. Little, Brown and Company. Boston /Toronto/London, 1991, 1: 3-17.
6. Roberts E., Chase T.N., Tower D.B.: GABA in nervous system function. Raven Press, New York, 1976.
7. Tillakavante N.J., Erlander M.G., Collard M.W., et al: Glutamate decarboxylase in non neural cells of the rat testis and oviduct: differential expression of GAD 65 and GAD. 67. J. Neurochem. 58: 618-627. 1992.
8. Alford S., Grr S.: The involvement of GABA-B receptors and coupled G-proteins in spinal GABA-ergics presynaptic inhibition. J. Neurosci. 11: 3718-3726. 1991.
9. Bormann J.: Electrophysiology of GABA-A and GABA-B receptor subtypes. TINS 11 :112-116. 1988.
10. Zezula J., Fuchs K., Sieghart W.: Separation of α-1, α-2 and α-3 subunit of the GABA-A-benzodiazepinie receptor complex by immunoaffinity chromatography. Brain Res. 563: 325-28. 1991.
11. Davanger S., Ottersen O. P., Strom-Mathisen J.: GABA immunoreactive cells in the rat gastrointestinal epithelium. Anat. Embryol. 179: 221-22621. 1989.
12. Ong J., Kerr D. J.: GABA-receptors in peripheral tissues. Life Sci. 46: 1489-1501. 1990.
13. Gerber J. C., Hare T. A.: GABA in peripheral tissues, presence and action in endocrine pancreatic function. Brain Res. Bull. 5: 341-346. 1980.
14. Linsalata M., Russo F., Cavallini A. et al: Polyamines, diamine oxidase and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucose. Dis. Colon Rectum 7: 662-667. 1993.
15. Kleinrok Z., Matuszek M., Matuszek B., Jesipowicz J., Opolski A., Radzikowski C.: GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J. Physiol. Pharmacol. 49: 303-310, 1998.
16. Jussofie A., Reinhardt V., Kallf R.: GABA binding sites: their density, their affinity to muscimol and their behaviour against neuroactive steroids in human gliomas of different degrees of malignancy. J Neural Transm. Gen. Sect. 96: 233-241. 1994.
17. Pine M. J., Kim U., Ip C.: Free amino acid pools of rodent mammary tumors. J Natl. Cancer Inst. 69: 729-35. 1982.
18. Tong Y., Rheaume E., Simard J., Pelletier G.: Localization of peripheral benzodiazepine binding sites and diazepam-binding inhibitor (DBI) mRNA in mammary glands and dimethylbenz(a)antracene (DMBA)-induced mammary tumors in the rat. Regul.-Pept. 33: 263-73. 1991.
19. Kupczyk-Subotkowska L., Siahaan T. J., Basile A. S. et al.: Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate J. Med. Chem. 40: 1726-30. 1997.
20. Batra S., Alenfall J.: Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma. Prostate 24: 269-78. 1994.
21. Mazurkiewicz M., Opolski A., Wietrzyk J., Radzikowski C., Kleinrok Z.: GABA content and GAD activity in normal mouse mammary gland tissue and in 16/C mammary cancer cells. Med. Sci. Monit. 4: 596-599, 1998.
22. Mazurkiewicz M., Wietrzyk J., Opolski A., Radzikowski C., Kleinrok Z.: Effect of baclophen on the growth of 16/C transplantable mouse mammary adenocarcinoma in vivo. Med. Sci. Monit. 1999 in press.
23. Lowe J. P., Robins E., Eyerman G. S.: The fluorimetric measurement of glutaminic decarboxylase and distribution in brain. J. Neurochem. 3: 8-18. 1958.
24. Sutton J., Simmonds M. A.: Effects of acute and chronic pentobarbitone on the γ-aminobutyric acid system in rat brain. Bioch. Pharmacol. 23: 1801-1808. 1974.
25. Cricco G. P., Davio C. A., Bergoc R. M. et al: Inhibition of tumor growth inducal by histamine: in vivo and in vitro studies. Agents Actions 38 Special Conference Issue. C: 175-177. 1983.
26. Davio C. A., Cricco G. P., Andrade N. et al: H1 and H2 histamine receptors in human mammary carcinomas. Agents Actions 38 Special Conference Issue. C: 172-174. 1983.
27. Orzechowska-Józwenko K.: Tumor chemotherapy (in Polish). PZWL, Warszawa, 1990. 2:54-57.
28. Sznajda J.: Clinical biochemistry in medicine (in Polish). PZWL, Warszawa, 1983. 19: 696-697.
29. Curtis D. R., Johnston G. A. R.: Amino acid transmitters in the mammalian central nervous system. Ergeb. Physiol. 69: 97-188. 1974.
30. Ferenci P., Stehle T., Ebners S., et al: Uptake and catabolism of γ-aminobutyric acid by the isolated perfused rat liver. Gastroenterology 95: 402-407. 1988.
31. Yamasaki K., Goto Y.: Direct evidence for central action of baclofen to stimulate gastric acid secretion by intracisternal inspection. Jap. J. Pharmacol. 54: 7-12. 1990.
32. Horsman M. R., Overgaard J.: The oxygen effect. In: Basic Clinical Radiobiology for Radiation Oncologists (Steel GG Ed.), Edward Arnold Publishers. 1993 81-88.
33. Kaur G., Sharma P., Bhardway S. et al.: GABA agonists and neurotransmitters metabolizing enzymes in steroid-primed rats. Mol. Cell. Biochem. 167: 107-111. 1997.
34. Tatsuta M., Iishi H., Baba M. et al: Protection by muscimol against gastric carcinogenesis induced by N-Methyl-N'-Nitro-N-Nitrosoguanidine in spontaneously hypertensive rats. Int. J. Cancer 52: 924-927. 1992.
35. Tatsuta M., Iishi H., Baba M., et al: Attenuation by the GABA receptor agonist baclofen of experimental carcinogenesis in rat colon by azoxymetane. Oncology 49: 241-245. 1992.
36. Cellotti F., Apud J. A., Rovescalli A. C. Et al.: The GABAergic extrinsic innervation of the rat fallopian tubes: biochemical evidence and endocrine modulation. Adv. Biochem. Psychopharmacol. 42: 251-264. 1986.
37. Paszko Z.: Hormones in mammary cancer (in Polish). Nowotwory 28: 233-240. 1978.
38. Teter J., Paszko Z., Gadomska H.: Prolactine level and cancer risk in patients with mastopathy (in Polish). Nowotwory 33: 193-202. 1982.